Posts by VIVA! Communications
Impact on COVID-19 on cancer diagnosis, treatment & patient mental health
Insights from Professor Stephen Clarke OAM This week, VIVA! Communications’ Principal, Kirsten Bruce spoke with award-winning Medical Oncologist, Pharmacologist and Translational Researcher, Professor Stephen Clarke OAM, Sydney, about clinical practice during COVID-19, the impact of the virus on cancer diagnosis and treatment, and how cancer patients are faring from a mental health perspective. Although the…
Read MoreNew combination therapy now reimbursed for Aussies living with incurable blood cancer
Yesterday, VIVA! partnered with Celgene, a Bristol-Myers Squibb company and Myeloma Australia to announce the listing of REVLIMID® (lenalidomide) in combination with bortezomib (Velcade) and dexamethasone (RVd) on the Pharmaceutical Benefits Scheme (PBS). Australians living with the incurable blood cancer, multiple myeloma now have access to this new treatment option. The three drug regimen will…
Read MoreCEO of Epilepsy Action Australia slams “appalling” TikTok ‘seizure challenge’ trend
CEO of Epilepsy Action Australia, Carol Ireland, released a public statement yesterday, following a recent controversial viral trend on the video app TikTok, known as the “seizure challenge”. Ms Ireland commented she is “appalled that people are pretending to have seizures as if it’s a joke”. The latest challenge to have gone viral on TikTok,…
Read MoreTop tips for WFH video calls
How to avoid faux pas & respect your fellow zoomies Working from home presents unique challenges and opportunities for those fortunate enough to be able to do so. Businesses and their employees are doing their best to navigate these unprecedented times, so it’s important to practice patience and respect. Here at VIVA! we are doing…
Read MoreAussies with CVD at higher risk from COVID-19
Tracking the incidence of COVID-19 globally, it is understood that people over the age of 60 with a pre-existing chronic condition, such as cardiovascular disease (CVD) or diabetes, are considered at greater risk to serious infection and complications.1 There has been a high prevalence of CVD in those dying from COVID-19 in Italy and China, two of the worst…
Read More